Roles of CD147 on T lymphocytes activation and MMP-9 secretion in Systemic Lupus Erythematosus

43Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

The cellular and molecular mechanisms involved in many abnormalities described in Systemic Lupus Erythematosus (SLE) are still unclear. Some of these abnormalities referred to the hyperactivation of T lymphocytes and the enhanced secretion of MMP-9 by peripheral blood mononuclear cells (PBMCs). Therefore, in this paper we investigated the potential role of CD147 molecule in these abnormalities. Our results demonstrated that CD147 molecule is overexpressed on CD3+T lymphocytes from SLE patients when compared with CD3+T lymphocytes from healthy donors. Monoclonal anti-CD147 antibodies, MEM-M6/1 clone, were able to inhibit protein tyrosine phosphorylation only in CD3 × CD28 costimulated T lymphocytes from SLE patients. However, this monoclonal antibody was unable to inhibit the enhanced activity of MMP-9 secreted by SLE PBMCs. © 2007 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Pistol, G., Matache, C., Calugaru, A., Stavaru, C., Tanaseanu, S., Ionescu, R., … Stefanescu, M. (2007). Roles of CD147 on T lymphocytes activation and MMP-9 secretion in Systemic Lupus Erythematosus. Journal of Cellular and Molecular Medicine, 11(2), 339–348. https://doi.org/10.1111/j.1582-4934.2007.00022.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free